256940 — Keeps BioPharma Cashflow Statement

0.000.00%

Last trade - 00:00

TechnologySpeculativeSmall CapMomentum Trap

Annual cashflow statement for Keeps BioPharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-2,547	-16,231	-12,040	3,463	1,612
Depreciation
Amortisation
Non-Cash Items	2,716	8,605	6,034	698	5,129
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-2,510	-1,567	4,147	-5,660	-4,514
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-1,737	-8,380	-866	-57.1	4,808
Capital Expenditures	-1,692	-123	-130	-1,071	-6,700
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-7,839	-14,154	-9,297	-26,520	-15,575
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-9,531	-14,276	-9,427	-27,591	-22,275
Financing Cash Flow Items	-42.4	-35.7	-298	-600	31,649
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	38,690	28,032	-3,272	8,151	31,927
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	26,744	6,049	-13,572	-19,519	14,671